Eric Joseph
Stock Analyst at Citi
(4.44)
# 1,184
Out of 4,683 analysts
335
Total ratings
52%
Success rate
11.2%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintained: Buy | $355 → $360 | $252.99 | +42.30% | 2 | Aug 14, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Hold | $93 → $94 | $80.40 | +16.92% | 5 | Aug 12, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $380 → $340 | $240.08 | +41.62% | 4 | Aug 3, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $100 | $63.57 | +57.31% | 4 | Jul 22, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $80 → $76 | $66.12 | +14.94% | 5 | Jul 16, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $99 | $77.46 | +27.81% | 3 | Jul 16, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $67 → $108 | $73.47 | +47.00% | 31 | Jun 10, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $46 → $49 | $55.42 | -11.58% | 18 | Nov 3, 2025 | |
| PLRX Pliant Therapeutics | Downgraded: Sell | n/a | $1.19 | - | 7 | Oct 10, 2025 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $48 | $31.03 | n/a | 20 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $64 | $126.64 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $3.78 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $9.44 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.71 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $4.45 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $41.30 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $11 | $20.57 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $10.71 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.49 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $12 | $14.56 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $21 | $5.25 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $70 | $211.38 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $5 | $14.08 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $26.95 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $1.73 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $7 | $4.20 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $10 | $3.56 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $15.49 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $2.17 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $5.43 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $2.44 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $23.36 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $1.92 | n/a | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $4.39 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $7.47 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $7 | $2.24 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.9584 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $8.54 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $19.28 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.0001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $39 → $26 | $46.36 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.28 | n/a | 1 | Feb 7, 2020 |
Ascendis Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $355 → $360
Current: $252.99
Upside: +42.30%
BridgeBio Pharma
Aug 12, 2026
Maintained: Hold
Price Target: $93 → $94
Current: $80.40
Upside: +16.92%
Alnylam Pharmaceuticals
Aug 3, 2026
Maintained: Buy
Price Target: $380 → $340
Current: $240.08
Upside: +41.62%
Ionis Pharmaceuticals
Jul 22, 2026
Maintained: Buy
Price Target: $100
Current: $63.57
Upside: +57.31%
BioMarin Pharmaceutical
Jul 16, 2026
Maintained: Buy
Price Target: $80 → $76
Current: $66.12
Upside: +14.94%
Cytokinetics
Jul 16, 2026
Maintained: Buy
Price Target: $99
Current: $77.46
Upside: +27.81%
PTC Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $67 → $108
Current: $73.47
Upside: +47.00%
TG Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $46 → $49
Current: $55.42
Upside: -11.58%
Pliant Therapeutics
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $1.19
Upside: -
Beam Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $31.03
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $126.64
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $3.78
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $9.44
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.71
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $22 → $18
Current: $4.45
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: n/a
Current: $41.30
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $21 → $11
Current: $20.57
Upside: n/a
May 7, 2025
Maintained: Hold
Price Target: $14
Current: $10.71
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.49
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $15 → $12
Current: $14.56
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $20 → $21
Current: $5.25
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $71 → $70
Current: $211.38
Upside: n/a
Feb 10, 2025
Maintained: Sell
Price Target: $9 → $5
Current: $14.08
Upside: n/a
Jan 29, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $26.95
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $1.73
Upside: n/a
Feb 23, 2024
Maintained: Hold
Price Target: $6 → $7
Current: $4.20
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $11 → $10
Current: $3.56
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $15.49
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $2.17
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $5.43
Upside: n/a
May 5, 2023
Maintained: Hold
Price Target: $6 → $5
Current: $2.44
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $23.36
Upside: n/a
Nov 4, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $1.92
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $4.39
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $7.47
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $24 → $7
Current: $2.24
Upside: n/a
Mar 4, 2022
Maintained: Sell
Price Target: n/a
Current: $0.9584
Upside: n/a
Nov 11, 2021
Maintained: Hold
Price Target: $14 → $11
Current: $8.54
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $19.28
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.0001
Upside: n/a
Sep 21, 2020
Maintained: Hold
Price Target: $39 → $26
Current: $46.36
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $7.28
Upside: n/a